tirzepatide 2.5 mg/0.5 ml subcutaneous solution ZEPBOUND® Prefilled Syringe (Tirzepatide) 12.5mg/.5ml How Many Units Is 2.5

Seek emergency care immediately for chest pain, severe shortness of breath, or signs of severe allergic reaction

Comparable to other peptides linked to fatty acids (e.g., the insulins detemir and degludec, the GLP-1RA liraglutide and semaglutide), the fatty acid side chain allows binding to albumin after subcutaneous injection, slows enzymatic degradation and prolongs biological half-life ( In vitro signaling studies demonstrated that tirzepatide was able to activate the GIP receptor with comparable potency to native GIP ( in vitro and in vivo models used, tirzepatide was able to stimulate glucose-dependent insulin secretion via GIP and/or GLP-1 receptor activation

Gentle mixing, swirling rather than shaking, is typically recommended, since vigorous agitation can denature the peptide's tertiary structure and reduce activity in downstream assays

This leads to better blood sugar management without increasing the risk of hypoglycemia